Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

  • López-Anglada, Lucía|||0000-0003-1727-8546
  • Cueto-Felgueroso, Cecilia|||0000-0002-4329-9634
  • Rosiñol, Laura|||0000-0002-2534-9239
  • Oriol, Albert|||0000-0001-6804-2221
  • Teruel, Ana Isabel|||0000-0003-1559-7607
  • López de la Guía, Ana|||0000-0002-7705-7844
  • Bengoechea, Enrique
  • Palomera, Luis|||0000-0003-0359-7191
  • De Arriba, Felipe|||0000-0002-4451-1318
  • Hernandez, Jose Mariano
  • Granell, Miquel|||0000-0002-0366-3673
  • Peñalver, Francisco Javier
  • García-Sanz, Ramón|||0000-0003-4120-2787
  • Besalduch, Joan
  • Gonzalez Montes, Yolanda|||0000-0002-4471-5142
  • Martinez, Rafael Benigno
  • Hernández, Miguel Teodoro|||0000-0002-6576-7881
  • Gutierrez, Norma C.
  • Puerta, Paloma
  • Valeri, Antonio
  • Paiva, Bruno|||0000-0003-1977-3815
  • Bladé Creixenti, Juan|||0000-0002-4563-3405
  • Mateos, M. V.|||0000-0003-2390-1218
  • San Miguel, Jesús|||0000-0002-9183-4857
  • Lahuerta, J. J.|||0000-0002-3393-9570
  • Martínez-López, Joaquín|||0000-0001-7908-0063
We investigated the prognostic impact and clinical utility of serum free light chains (sFLC) and serum heavy-light chains (sHLC) in patients with multiple myeloma treated according to the GEM2005MENOS65, GEM2005MAS65, and GEM2010MAS65 PETHEMA/GEM phase III clinical trials. Serum samples collected at diagnosis were retrospectively analyzed for sFLC (n = 623) and sHLC (n = 183). After induction or autologous transplantation, 309 and 89 samples respectively were available for sFLC and sHLC assays. At diagnosis, a highly abnormal (HA) sFLC ratio (sFLCr) (<0.03 or.